Wenyu Ye Selected Research

Wenyu Ye Research Topics

Disease

11	Schizophrenia (Dementia Praecox) 04/2015 - 06/2009
10	Migraine Disorders (Migraine) 01/2022 - 06/2019
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 06/2009 - 11/2005
3	Pain (Aches) 06/2021 - 01/2011
3	Major Depressive Disorder (Major Depressive Disorders) 01/2011 - 01/2007
2	Headache (Headaches) 06/2021 - 04/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 01/2020
2	Chronic Pain 11/2020 - 08/2010
2	Dementia (Dementias) 01/2019 - 01/2017
2	Osteoporosis 11/2016 - 01/2015
2	Substance-Related Disorders (Drug Abuse) 09/2010 - 11/2005
2	Mental Disorders (Mental Disorder) 06/2009 - 08/2006
2	Tics (Tic) 08/2006 - 11/2005
2	Alcoholism (Alcohol Abuse) 04/2006 - 11/2005
1	Disease Progression 11/2020
1	Bronchiolitis 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Bronchitis 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2016
1	Spontaneous Fractures (Pathological Fracture) 01/2015
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 07/2014
1	Neoplasm Metastasis (Metastasis) 07/2014
1	Neoplasms (Cancer) 07/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014
1	Mania (Manias) 01/2014
1	Weight Gain 01/2014
1	Neurobehavioral Manifestations 01/2011
1	Infections 03/2009
1	Diabetes Complications 03/2009
1	Neurologic Manifestations (Neurological Manifestations) 03/2009
1	Heart Diseases (Heart Disease) 03/2009
1	Ketosis 03/2009
1	Sleep Wake Disorders 08/2006
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2006
1	Obesity 11/2005

Drug/Important Bio-Agent (IBA)

8	Antipsychotic Agents (Antipsychotics)IBA 04/2015 - 04/2006
7	Olanzapine (Zyprexa)FDA Link 01/2014 - 01/2011
3	galcanezumabIBA 01/2022 - 01/2022
3	Monoclonal AntibodiesIBA 01/2022 - 01/2022
3	Calcitonin Gene-Related PeptideIBA 01/2022 - 01/2022
3	Tryptamines (Triptans)IBA 06/2021 - 04/2020
3	Pharmaceutical PreparationsIBA 11/2020 - 11/2005
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 08/2006 - 11/2005
2	erenumabIBA 01/2022 - 01/2022
2	fremanezumabIBA 01/2022 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2012 - 01/2012
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2012 - 01/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2011 - 04/2006
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2011 - 01/2007
1	LigandsIBA 01/2022
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2022
1	ubrogepantIBA 01/2022
1	rimegepant sulfateIBA 01/2022
1	lasmiditanIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	solanezumabIBA 01/2017
1	Raloxifene Hydrochloride (Evista)FDA Link 11/2016
1	ElementsIBA 01/2015
1	PlatinumIBA 07/2014
1	Serum AlbuminIBA 07/2014
1	Gemcitabine FDA Link 07/2014
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2011
1	BenzodiazepinesIBA 08/2010
1	Hypnotics and Sedatives (Sedatives)IBA 08/2010
1	Anti-Anxiety Agents (Anxiolytics)IBA 08/2010
1	Clonidine (ST 155)FDA LinkGeneric 08/2006

Therapy/Procedure

11	Therapeutics 01/2021 - 11/2005
2	Length of Stay 01/2015 - 01/2015
1	Injections 01/2022
1	Polypharmacy 01/2012
1	Surgical Amputation (Amputations) 03/2009